Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
University hospital, Saint-Etienne, France
Royal Perth Hospital, Perth, Western Australia, Australia
Waikato Hospital, Hamilton, New Zealand
Royal Melbourne Hospital, Parkville, Victoria, Australia
Hospital Pompeia, Caxias do Sul, RS, Brazil
Hospital Medianeira, Caxias do Sul, RS, Brazil
General Hospital of Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil
GSK Investigational Site, Palermo, Sicilia, Italy
Klinik fuer Anaesthesiologie am Universitätsklinikum Schleswig Holstein, Campus Luebeck, Lubeck, Germany
Klinik fuer Anaesthesiologie der Ludwigs-Maximilians-Universitaet Muenchen, Munich, Germany
Krankenhaus Friedrichshafen, Friedrichshafen, Germany
Stanford University Medical Center, Stanford, California, United States
Departments of Intensive Care Medicine and Anesthesiology, Bern, BE, Switzerland
Technische Universität München, Klinikum rechts der Isar, Department of Anesthesiology, Munich, Bavaria, Germany
Royal Melbourne Hospital, Melbourne, Victoria, Australia
st. Antonius hospital, Nieuwegein, Netherlands
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.